Prosztatarák: vizsgálatok itt: Hollandia
68 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 18.. Ask the study team whether a trial fits you.
- 1/2. fázisNot yet taking people in HollandiaA Study to Learn How Safe AZD6621 is, How Well it Works, and How it Moves Throughout the Body Over Time, in Adult Male Participants With Metastatic Prostate Cancer
- Where
- Amsterdam, Maastricht
- Életkor
- 18 év and over
- People
- 52 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07192614 · EU 2025-520626-37-00 - No phaseTaking peopleIrreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 27
- Run by
- Amsterdam UMC, location VUmc
See details and how to joinNCT07782164 - 1. fázisTaking peopleFirst-in-human Study of 225Ac-PSMA-Trillium (BAY 3563254) in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)
- Where
- Groningen, Rotterdam
- Életkor
- 18 év and over
- People
- 198 worldwide
- Run by
- Bayer
See details and how to joinNCT06217822 · EU 2023-507486-26-00 - 4. fázisTaking peopleLong-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
- Where
- Delft, Maastricht, Nijmegen
- Életkor
- 18 év to 100 év
- People
- 700 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT05803941 · EU 2023-503208-94-00 - 4. fázisNot yet taking people in HollandiaComparison of standard abiraterone dosing and dosing based on abiraterone blood levels
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 230
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2025-524440-35-00 - No phaseTaking peopleHigh-Risk prostatE Cancer radiatiOn Versus surgERy
- Where
- Alkmaar, Amsterdam, Assen, Beverwijk, Dordrecht, Eindhoven, Goes, Groningen, Hardenberg, Harderwijk, Hoofddorp, Hoogeveen, Hoorn, Leiden, Nijmegen, Rotterdam, Scheemda, The Hague, Tilburg, Veldhoven, Zaandam
- Életkor
- 50 év to 75 év
- People
- 837
- Run by
- Comprehensive Cancer Centre The Netherlands
See details and how to joinNCT05931419 - 1/2. fázisTaking peopleAnti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
- Where
- Amersfoort, Nijmegen
- Életkor
- 18 év and over
- People
- 82 worldwide
- Run by
- Blue Earth Therapeutics Ltd
See details and how to joinNCT05413850 · EU 2024-511537-35-00 - 3. fázisTaking peopleADT +/- Darolutamide in de Novo Metastatic Prostate Cancer Patients With Vulnerable Functional Ability (PEACE6-Vulnerable)
- Where
- Beugen, Dordrecht, Nijmegen
- Életkor
- 18 év and over
- People
- 300 worldwide
- Run by
- UNICANCER
See details and how to joinNCT04916613 · EU 2022-502425-18-00 - No phaseTaking peopleLab Research Using Mini-tumors to Study Prostate Cancer Treatments
- Where
- Heerlen, Maastricht
- Életkor
- 18 év and over
- People
- 600
- Run by
- Maastricht Radiation Oncology
See details and how to joinNCT07004582 - 1/2. fázisNot yet taking people in HollandiaClinical Application of the Androgen Receptor Inhibitor Darolutamide to Upregulate the Prostate-Specific Membrane Antigen (PSMA) Protein Expression in Patients with Hormone Sensitive Prostate Cancer. - The DARO-flare Trial -
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 32
- Run by
- Amsterdam UMC Stichting
See details and how to join2025-520482-52-03 - 2. fázisTaking peopleDAROTAXEL
- Where
- Almelo, Amsterdam, Apeldoorn, Deventer, Dordrecht, Drachten, Geleen, Goes, Leeuwarden, Nijmegen, Roosendaal, Rotterdam, Schiedam, 's-Gravenhage, 'S-Hertogenbosch, Utrecht, Zwolle
- Életkor
- 18 év and over
- People
- 245
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-516939-28-00 - No phaseTaking peopleThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Amsterdam, Deventer, Leeuwarden, Nijmegen, Utrecht
- Életkor
- 18 év and over
- People
- 8000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleUtrecht Prostate Cohort for Cancer Treatment Intervention Studies and Long-term Evaluation
- Where
- Nieuwegein, Utrecht
- Életkor
- 18 év and over
- People
- 1500
- Run by
- UMC Utrecht
See details and how to joinNCT04228211 - No phaseTaking peopleEREctile Function Preservation for Prostate Cancer Radiation Therapy (ERECT)
- Where
- Utrecht
- Életkor
- 18 év and over
- People
- 70
- Run by
- UMC Utrecht
See details and how to joinNCT04861194 - No phaseTaking peopleDetection of Minimal Residual Disease Post-prostatectomy
- Where
- Nijmegen
- Életkor
- 18 év and over
- People
- 50
- Run by
- Radboud University Medical Center
See details and how to joinNCT07334275 - No phaseTaking peopleSequential Imaging of Suspicion of Prostate Cancer Reducing Overdiagnosis and Unnecessary Biopsy With Timely Diagnosis of Significant Cancer
- Where
- Amsterdam, Arnhem, Emmen, Nieuwegein, Nijmegen, Rotterdam
- Életkor
- 18 év and over
- People
- 503
- Run by
- St. Antonius Hospital
See details and how to joinNCT07180381 - 3. fázisTaking peopleShortened 12 months duration of androgen receptor signalling agent in combination with androgen deprivation therapy in patients with low-volume castration-sensitive prostate cancer: a randomized Nationwide Study
- Where
- Alkmaar, Almelo, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen, Enschede, Goes, Groningen, Haarlem, Hilversum, Leeuwarden, Maastricht, Nieuwegein, Nijmegen, Roermond, Roosendaal, Rotterdam, 's-Gravenhage, 'S-Gravenhage, Venlo
- Életkor
- 18 év and over
- People
- 400
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-506698-36-00 - 3. fázisTaking peopleApa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer
- Where
- Alkmaar, Amersfoort, Amsterdam, Assen, Beverwijk, Deventer, Eindhoven, Emmen, Enschede, Goes, Groningen, Haarlem, Hengelo, Hilversum, Leeuwarden, Maastricht, Nijmegen, Roermond, Roosendaal, Rotterdam, The Hague, Utrecht, Venlo
- Életkor
- 18 év and over
- People
- 400
- Run by
- Nick Beije
See details and how to joinNCT07260435 - 1/2. fázisTaking peoplePhase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
- Where
- Maastricht, Rotterdam
- Életkor
- 18 év and over
- People
- 126 worldwide
- Run by
- Maastricht University Medical Center
See details and how to joinNCT04954599 - No phaseNot yet taking people in HollandiaOligoCare TwiCs (Trials Within Cohorts) Trial Comparing Acute Toxicity in Single-fraction vs Multiple-fraction SBRT for Metastasis-directed Treatment (SPRINT)
- Where
- Deventer, Nijmegen
- People
- 302 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06462963 - No phaseTaking peopleFeasibility of CBCT-Guided Online Adaptive Radiotherapy (FASCINATE)
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 100
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06691776 - 1/2. fázisNot yet taking people in HollandiaDUAL
- Where
- Amsterdam
- Életkor
- 18 év and over
- People
- 13
- Run by
- Het Nederlands Kanker Instituut-Antoni van Leeuwenhoek Ziekenhuis Stichting
See details and how to join2023-505453-40-00 - No phaseTaking peopleThe Radium-select Study
- Where
- Amersfoort, Amsterdam, Nieuwegein, Utrecht
- Életkor
- 18 év and over
- People
- 60
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06659926 - 1. fázisTaking peoplePhase I study of 225Ac-PSMA I&T in prostate cancer
- Where
- Rotterdam
- Életkor
- 18 év and over
- People
- 30
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2024-513729-22-01 - 2. fázisTaking peopleThe Impact of Metastatic Directed Radiotherapy (MDRT) on Oligoprogressive Castration Resistant Prostate Cancer (CRPC)
- Where
- Groningen, Nijmegen
- Életkor
- 18 év and over
- People
- 35
- Run by
- University Medical Center Groningen
See details and how to joinNCT07038304